Clinical Outcome Study of Medial Patellofemoral Ligament Reconstruction Surgery

Institutional Review Board, Hospital for Special Surgery

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Beth E. Shubin Stein, MD

Co-Investigators

Sabrina Strickland, MD

Douglas Mintz, MD

Joseph Nguyen

Irene Kalbian

 

Summary

This study is a review of the functional outcomes of MPFL reconstruction surgery for treating patellofemoral instability.

Inclusion/Exclusion Criteria

Inclusion:

Patients with patellofemoral instability who underwent MPFL reconstruction as     part of their surgical treatment

Exclusion:

Revision surgery patients

Contact Information

Beth E. Shubin Stein, MD

shubinsteinb@hss.edu

212.606.1752